Michael Kaplan, MD
Otolaryngology · Houston, TXNPI 1750443289
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $181,213 of the $201,980 with a category attached, or 89.7%. Stryker accounts for 91.6% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $102,670 and has fallen 86.9% since, to $13,460 in 2025. Among otolaryngology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 374 payments — averaging $540.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$185K
- Neurent Medical Limited$12K
- Intersect ENT, Inc.$2K
- Medtronic$569
- GSK$394
- Optinose US, Inc.$315
- plus $1K from 12 others
What the payments were for
- Consulting fees$181,21390%
- Travel & lodging$5,1983%
- Food & beverage$15,5708%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 259 | $185,019 |
| Neurent Medical Limited | 25 | $12,498 |
| Intersect ENT, Inc. | 15 | $1,978 |
| Medtronic | 6 | $569 |
| GSK | 16 | $394 |
| Optinose US, Inc. | 16 | $315 |
| 3-d Matrix, Inc. | 1 | $287 |
| Regeneron Healthcare Solutions, Inc. | 12 | $254 |
| Sanofi | 9 | $235 |
| Inspire Medical Systems, Inc. | 5 | $149 |
| Nalu Medical, Inc. | 1 | $68 |
| Aerin Medical Inc. | 2 | $63 |
| Encore Medical, LP | 2 | $50 |
| Acclarent, Inc | 1 | $28 |
| Integra Lifesciences Corporation | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Olympus America Inc. | 1 | $16 |
| Novartis | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENTELLUS - XPRESS ENT DILATION SYSTEM$106,337
- CLARIFIX CRYOTHERAPY DEVICE$66,300
- LATERA$51,757
- XPRESS ENT DILATION SYSTEM$34,171
- ORTHOMAP$25,500
- SCOPIS ENT$23,265
- SHAVER SYSTEM$16,310
- NEUROMARK System$11,789
- NEUROMARK Radiofrequency Console$11,789
- PROPEL$1,983
- ENTELLUS - ENTELLUS MEDICAL SHAVER SYSTEM$428
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM$414
- AUDION ET DILATION SYSTEM$316
- SINUVA$275
- ENTELLUS - FOCESS SINUSCOPES$153
- ENTELLUS - FOCESS HD WIRELESS CAMERA$150
- SPIROX - LATERA$147
- NUCALA$122
How this compares
$201,980 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XhanceFluticasone Propionate | 15 | $9,630 |
| Ipratropium Bromide | 94 | $2,331 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 249 | $1,001 |
| Amoxicillin | 243 | $647 |
| Prednisone | 186 | $342 |
| Methylprednisolone | 52 | $325 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 42 | $291 |
| Ciprofloxacin Hcl | 25 | $282 |
| Doxycycline Hyclate | 30 | $251 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 46 | $208 |
| Pantoprazole Sodium | 12 | $142 |
| Lorazepam | 106 | $126 |
| Levofloxacin | 22 | $125 |
| Mupirocin | 13 | $95 |
| Promethazine Hcl | 51 | $72 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $315 | $9,63015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 729 otolaryngology providers in Texas.
Other otolaryngology in Houston
- Amber LuongHouston$426K
- Arjuna KuperanHouston$348K
- Ron KarniHouston$317K
- Martin CitardiHouston$245K
- Masayoshi TakashimaHouston$167K
- William YaoHouston$154K
- Andrew HuangHouston$137K
- Manish WaniHouston$100K
- Shane PahlavanHouston$95K
- Omar AhmedHouston$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.